Indirect comparison between abiraterone acetate and enzalutamide for the treatment of metastatic castration-resistant prostate cancer: a systematic review

Indirect comparison between abiraterone acetate and enzalutamide for the treatment of metastatic castration-resistant prostate cancer: a systematic review

This study was designed to evaluate the efficacy, tolerability, and sequential administration of abiraterone acetate (AA) and enzalutamide (Enz) for metastatic castration-resistant prostate cancer (mCRPC). A literature search was performed with PubMed, Embase, and Web of Science databases to identif...

Full description

Bibliographic Details
Main Authors: Wei Zhang, Teng-Yun Wu, Qi Chen, Xiao-Lei Shi, Guang-An Xiao, Lin Zhao, Chuan-Liang Xu, Tie Zhou, Ying-Hao Sun
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Asian Journal of Andrology
Subjects:
abiraterone acetate; enzalutamide; indirect comparison; metastatic castration-resistant prostate cancer; sequential therapy
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2017;volume=19;issue=2;spage=196;epage=202;aulast=Zhang

Internet

http://www.ajandrology.com/article.asp?issn=1008-682X;year=2017;volume=19;issue=2;spage=196;epage=202;aulast=Zhang

Similar Items